Beijing Wantai Biological Pharmacy Enterprise Co Ltd

Wantai Bio's actual controller Zhong Shanshan has completed the transfer registration of 33 million unrestricted tradable shares donated free of charge to the Fujian Xiang'an Innovation Laboratory Science and Technology Development Foundation. The combined shareholding of Zhong and his concert party Yangshengtang Co., Ltd. in the listed company has fallen from 73.53% to 70.92%, with the equity change reaching the 1% threshold. The donated shares account for 2.61% of the company's total share capital. After the transfer, Zhong's direct shareholding decreased from 223,951,071 shares to 190,951,071 shares, with his stake falling from 17.71% to 15.10%, while Yangshengtang's shareholding remains unchanged. The announcement stated that this equity change does not trigger a mandatory tender offer and will not lead to a change in the controlling shareholder or actual controller. Wantai Bio achieved operating revenue of 1.048 billion yuan in the first half of the year, up 24.29% year on year, while net profit attributable to the parent company was negative 128 million yuan, with losses narrowing. The revenue growth was mainly driven by the ramp-up of the nine-valent HPV vaccine after its launch. As of the close on September 4, the company's share price stood at 27.67 yuan, with a cumulative decline of about 38.43% since the beginning of 2026.

Wus Printed Circuit, Jiangxi Copper and several other companies released their 2026 semi-annual reports. Wus Printed Circuit's first-half net profit rose 73.72% year on year, while Jiangxi Copper's net profit rose 106.77%. Huashengchang's first-half net profit grew 73%, with second-quarter net profit up 223% quarter on quarter. JPT's 2026 semi-annual net profit rose 105.25% year on year. Naura Technology's first-half net profit rose 5.05% year on year. In addition, Zhong Shanshan, the actual controller of Wantai Biological Pharmacy, donated 33 million company shares free of charge to the Fujian Xiang'an Innovation Laboratory Science and Technology Development Foundation, accounting for 2.61% of the company's total share capital.